Jonathan is an experienced trial lawyer who has been involved in both actions and applications before the Federal Court and Federal Court of Appeal involving intellectual property rights and remedies. Jonathan received a Bachelor of Science in Chemistry from the University of Waterloo, where he completed work terms with a multinational brand pharmaceutical company as well as with an IP boutique law firm. Jonathan was a litigation associate in the intellectual property department of a national firm prior to joining Aitken Klee LLP. Jonathan has appeared and presented arguments before the Federal Court of Canada.
- Successfully represented Ratiopharm Inc. in a patent validity action and appeal for the drug Norvasc (2009 FC 711).
- Represented Teva Canada Limited in quantification of damages following a patent validity action (2016 FC 593); and currently representing Teva Canada Limited in an action to quantify Section 8 damages under the PM(NOC) Regulations
- Represented Suncor Energy Inc. in a patent infringement and validity suit involving environmental remediation technology for the oil sands. (Federal Court T-1749-11).
- Represented Teva Canada Limited in several successful applications before the Federal Court under the Patented Medicines (Notice of Compliance) Proceedings.
- Acted for Re:Sound in copyright enforcement actions in the Federal Court of Canada. (T-1162-12; T-1738-12).
Intellectual Property Institute of Canada
Canadian Bar Association
Accolades and Recommendations
While completing his J.D. at Osgoode Hall Law School, Jonathan was the recipient of the Nathan Strauss, Q.C. Essay Prize in Legal Ethics, the Maritime Law Prize in Legal Ethics and the Gowlings LLP Best Blog in IP Law.